Actavis expands presence in India
Icelandic pharmaceutical Actavis has snapped up an Indian manufacturing plant in a move to take advantage of lower manufacturing costs for exports to the US and Europe.
Icelandic pharmaceutical Actavis has snapped up an Indian manufacturing plant in a move to take advantage of lower manufacturing costs for exports to the US and Europe.
US drug packaging manufacturer Brady has bought a Brazilian label maker in a bid to expand its operations not only in Brazil but throughout Latin America - an area considered by analysts to have a great business potential.
Pfizer has entered a capacity expansion phase, to meet requirements of global manufacturing of Genotropin (somatropin), a top-selling human growth hormone.
A number of executives and technical staff at small to medium size pharmaceutical firms are unaware of how to use their resources effectively to comply with new EMEA guidelines, designed to minimise the environmental impact of compounds, according to...
Agilent has expanded its service provider network allowing greater worldwide-access to certified genomics research capabilities.
Millipore Bioprocessing has once again decided to extend a development services contract with Angel Biotechnology for the next twelve months.
Quintiles has formed a new alliance with a hospital near its headquarters in North Carolina, from where it has begun running clinical trials on experimental drugs.
Giant drug maker Eli Lilly has confirmed that it will be closing its manufacturing facility in Basingstoke, England, resulting in $85m to $95m in restructuring costs for the company.